-
Namami Gange project: Let the rivers talk to each other
11 Jul 2025 01:51 GMT
… these shifts only after the Sandoz disaster in 1986.
The NMCG …
-
Denosumab Updates: Wyost and Jubbonti Launch as First Denosumab Biosimilars in the U.S.
10 Jul 2025 18:13 GMT
On June 2, 2025, Sandoz announced that WYOST® (denosumab-bbdz) …
-
Behavioral Rehabilitation Market Surpasses USD 171.88 Billion in 2025, Fueled by Anxiety and Substance Abuse Disorders
10 Jul 2025 14:00 GMT
… to essential mental health treatments.
Sandoz AG
Division of Novartis delivers … plc
Zynerba Pharmaceuticals
Apotex Inc.
Sandoz AG
Strides Arcolab Ltd.
TOLMAR …
-
Cannabinoid Agonist Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
10 Jul 2025 17:00 GMT
… LLC, Jazz Pharmaceuticals, Alkahest Inc., Sandoz, Sio Gene Therapies, Axovant Sciences …
-
Cancer Supportive Care Drugs Market to Reach $24.40 Bn, Globally, by 2030 at 2.2% CAGR: Allied Market Research
10 Jul 2025 12:39 GMT
… ,)
• Merck KGAA
• Novartis International AG (Sandoz)
• Teva Pharmaceuticals
Frequently Asked Questions …
-
Antifibrinolytic Drugs Market to Hit $19.3 Billion by 2026 Amid Rising Demand for Hemorrhage Control
10 Jul 2025 06:14 GMT
… N.V.,
Novartis International AG (Sandoz),
Pfizer Inc.,
Sanofi S.A …
-
Rand Paul's tweets highlight tariff concerns and legislative collaboration
10 Jul 2025 03:54 GMT
… on pharmaceutical companies such as Sandoz. He stated that such measures …
-
Two More Pairs of Denosumab Biosimilars Enter US Market
09 Jul 2025 23:14 GMT
… competitors follow the launches of Sandoz’ Wyost and Jubbonti (denosumab-bbdz …
-
Hims & Hers Introduces Affordable Semaglutide in Canada
09 Jul 2025 23:02 GMT
… of other competitors, such as Sandoz, which has already filed for …
-
Hims & Hers to offer generic semaglutide in Canada as Novo Nordisk patent lapses
09 Jul 2025 13:27 GMT
… for some in the industry.
Sandoz, a global leader in generic …